Skip to content

Category: Health

MaRS Catalyst Fund invests in InVivo AI to improve the efficacy of drugs coming to market using machine learning

InVivo AI, a Montreal-based startup using machine learning to improve the generation, screening, and optimization of new medications, has announced a pre-seed financing with MaRS Catalyst Fund, Real Ventures, Panache Ventures, and Brightspark Ventures, among others. Founded in 2018 by Daniel Cohen, Therence Bois, Prudencio Tossou, and Sebastien Giguere, InVivo is developing novel algorithms to […]

Read More
MaRS Catalyst Fund invests in Inkblot to make mental health services more affordable, accessible and effective

Inkblot Therapy, a Toronto-based startup that makes mental health services affordable, accessible and more effective, announced a seed-stage financing round with MaRS Catalyst Fund and Active Impact Fund. Founded in 2016 by Dr. Arash Zohoor and Luke Vigeant, Inkblot provides quality mental health services over a secure online platform while measuring improvement and treatment outcomes. […]

Read More
Flosonics on track for global growth

When MaRS Catalyst Fund considered investing in Flosonics Medical, we immediately saw the potential in its technology. A smart bandage that can non-invasively monitor arterial blood flow in critically ill patients has a large addressable market among emergency facilities and – crucially for us – could save lives and improve health outcomes. One of Canada’s […]

Read More
MaRS Catalyst Fund joins US$9.5-million investment in CellAegis

MaRS Catalyst Fund is investing in CellAegis, a Canadian medical device company with promising technology to help substantially improve patient recovery from heart disease. CellAegis’ autoRIC® device is a portable and easy-to-administer therapy for reducing damage to tissues following a heart attack or cardiovascular procedures. The autoRIC Device has already been approved for use in […]

Read More